famotidine has been researched along with Infectious Diseases in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nightingale, SL | 1 |
1 other study available for famotidine and Infectious Diseases
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Certification; Clinical Trials as Topic; Communicable Diseases; Conflict of Interest; Drug Approval; | 1995 |